bioRxivPharmacology & Toxicology
Is Kambo psychoactive? Acute and subacute effects of the secretion of the Giant Maki Frog (Phyllomedusa bicolor) on human consciousness.
T. T. Schmidt, S. Reiche, C. L. C. Hage, F. Bermpohl, T. Majic
Abstract
Kambo is the name for the secretion of the Giant Leaf Frog (Phyllomedusa bicolor) containing a plethora of bioactive peptides. Originally, it is ritually used by different ethnicities from the Amazon basin as a remedy against bad luck in hunting. In the last twenty years, Kambo has spread to Western urban centers, often associated with the use of ayahuasca. Anecdotal reports claim beneficial effects on wellbeing and different medical and mental health conditions. However, to date it has been controversial if Kambo elicits altered states of consciousness. Here we retrospectively investigated acute and subacute psychological effects of Kambo in a sample of n = 22 anonymous users (n = 22, mean age: 39 years, {+/-} 8.5; 45.5% female), administering standardized questionnaires for the assessment of psychoactive effects. Acutely, participants reported psychological effects which remained on a mild to moderate level, but no psychedelic-type distortions of perception or thinking. In contrast, persisting effects were predominantly described as positive and pleasant, revealing surprisingly high measures of personal and spiritual significance. Subacute and long-term effects showed some overlap with the "afterglow" phenomena that follow the use of serotonergic psychedelics.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognition
P. Mallaroni, N. L. Mason, … J. G. Ramaekers·bioRxiv·Feb 16, 2023
- Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushrooms
R. J. Rakoczy, G. N. Runge, … M. S. McMurray·bioRxiv·Oct 19, 2023
- How does it feel to be on psilocybin? Dose-response relationships of subjective experiences in humans.
Tim Hirschfeld, Timo Torsten Schmidt·Journal of PsychopharmacologyPeer-reviewed·Mar 4, 2021
- Mind-manifesting? Examining naturalistic reports from psychedelics, cannabis, meditation, and dreams from the ALTERD mobile application
Conor H. Murray, Michael Angyus, … Martin Max Monti·bioRxiv·Aug 4, 2026
- Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activity
Federico Cavanna, Stephanie L. Muller, … Enzo Tagliazucchi·bioRxiv·Nov 30, 2021
- Electrical spiking of psilocybin fungi
A. Gandia, A. Adamatzky·bioRxiv·Jul 2, 2022